Hepatitis C Patients May Not Qualify for Pricey Drugs Unless Illness Is Advanced

November 4, 2014

(Washington Post) – In the past year, new hepatitis C drugs that promise higher cure rates and fewer side effects have given hope to millions who are living with the disease. But many patients whose livers aren’t yet significantly damaged by the viral infection face a vexing reality: They’re not sick enough to qualify for insurance coverage for the drugs that could prevent them from getting sicker.

Posted by

Posted in Healthcare, News, Pharma